OTCMKTS:ETBI

Eastgate Biotech Competitors

$0.0040
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.03
Volume53,200 shs
Average Volume152,505 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Eastgate Biotech (OTCMKTS:ETBI) Vs. DDXS, TNGN, ATTBF, ADTX, AGNPF, and LBTSF

Should you be buying ETBI stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Eastgate Biotech, including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), ADiTx Therapeutics (ADTX), Algernon Pharmaceuticals (AGNPF), and Almirall (LBTSF).

(DDXS) (OTCMKTS:DDXS) and Eastgate Biotech (OTCMKTS:ETBI) are both health technology companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Profitability

This table compares (DDXS) and Eastgate Biotech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(DDXS)N/AN/AN/A
Eastgate BiotechN/AN/AN/A

Valuation and Earnings

This table compares (DDXS) and Eastgate Biotech's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(DDXS)N/AN/AN/AN/AN/A
Eastgate BiotechN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and recommmendations for (DDXS) and Eastgate Biotech, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(DDXS)0000N/A
Eastgate Biotech0000N/A

Eastgate Biotech (OTCMKTS:ETBI) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.

Valuation & Earnings

This table compares Eastgate Biotech and (TNGN)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eastgate BiotechN/AN/AN/AN/AN/A
(TNGN)N/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations for Eastgate Biotech and (TNGN), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Eastgate Biotech0000N/A
(TNGN)0000N/A

Profitability

This table compares Eastgate Biotech and (TNGN)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Eastgate BiotechN/AN/AN/A
(TNGN)N/AN/AN/A

Abattis Bioceuticals (OTCMKTS:ATTBF) and Eastgate Biotech (OTCMKTS:ETBI) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends.

Profitability

This table compares Abattis Bioceuticals and Eastgate Biotech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abattis BioceuticalsN/AN/AN/A
Eastgate BiotechN/AN/AN/A

Valuation and Earnings

This table compares Abattis Bioceuticals and Eastgate Biotech's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abattis BioceuticalsN/AN/AN/AN/AN/A
Eastgate BiotechN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and target prices for Abattis Bioceuticals and Eastgate Biotech, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abattis Bioceuticals0000N/A
Eastgate Biotech0000N/A

ADiTx Therapeutics (NASDAQ:ADTX) and Eastgate Biotech (OTCMKTS:ETBI) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk and profitability.

Valuation & Earnings

This table compares ADiTx Therapeutics and Eastgate Biotech's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ADiTx TherapeuticsN/AN/AN/AN/AN/A
Eastgate BiotechN/AN/AN/AN/AN/A

Profitability

This table compares ADiTx Therapeutics and Eastgate Biotech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ADiTx TherapeuticsN/AN/AN/A
Eastgate BiotechN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and target prices for ADiTx Therapeutics and Eastgate Biotech, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ADiTx Therapeutics00103.00
Eastgate Biotech0000N/A

Summary

ADiTx Therapeutics beats Eastgate Biotech on 1 of the 1 factors compared between the two stocks.

Algernon Pharmaceuticals (OTCMKTS:AGNPF) and Eastgate Biotech (OTCMKTS:ETBI) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, risk and profitability.

Earnings and Valuation

This table compares Algernon Pharmaceuticals and Eastgate Biotech's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Algernon PharmaceuticalsN/AN/AN/AN/AN/A
Eastgate BiotechN/AN/AN/AN/AN/A

Profitability

This table compares Algernon Pharmaceuticals and Eastgate Biotech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Algernon PharmaceuticalsN/AN/AN/A
Eastgate BiotechN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for Algernon Pharmaceuticals and Eastgate Biotech, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Algernon Pharmaceuticals0000N/A
Eastgate Biotech0000N/A

Almirall (OTCMKTS:LBTSF) and Eastgate Biotech (OTCMKTS:ETBI) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations for Almirall and Eastgate Biotech, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Almirall01102.50
Eastgate Biotech0000N/A

Profitability

This table compares Almirall and Eastgate Biotech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AlmirallN/AN/AN/A
Eastgate BiotechN/AN/AN/A

Valuation and Earnings

This table compares Almirall and Eastgate Biotech's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AlmirallN/AN/AN/AN/AN/A
Eastgate BiotechN/AN/AN/AN/AN/A

Summary

Almirall beats Eastgate Biotech on 1 of the 1 factors compared between the two stocks.


Eastgate Biotech Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00Gap Down
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.57flat$0.00N/A0.00Gap Up
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.13flat$0.00N/A0.00Increase in Short Interest
Almirall logo
LBTSF
Almirall
0.5$15.00flat$0.00N/A0.00
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.08flat$0.00N/A0.00High Trading Volume
Gap Up
ARNI
Arno Therapeutics
0.5$0.01flat$0.00N/A0.00
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06flat$0.00N/A0.00News Coverage
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.65flat$0.00N/A0.00Gap Up
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.52flat$0.00N/A0.00
BMEA
Biomea Fusion
0.0N/AN/A$0.00N/A0.00High Trading Volume
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.18flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.03flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Up
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$23.32flat$0.00N/A0.00Decrease in Short Interest
News Coverage
CELZ
Creative Medical Technology
0.5$0.04flat$0.00N/A0.00Gap Down
Cybin logo
CLXPF
Cybin
1.0$1.40flat$0.00N/A0.00Gap Down
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.10flat$0.00N/A0.00High Trading Volume
News Coverage
Gap Down
GB Sciences logo
GBLX
GB Sciences
0.5$0.05flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
Genfit logo
GNFTF
Genfit
0.5$4.52flat$0.00N/A0.00Decrease in Short Interest
GMXAY
GENMAB A/S/S
0.5$35.23flat$0.00N/A0.00High Trading Volume
Genus logo
GENSF
Genus
0.7$69.40flat$0.00N/A0.00Decrease in Short Interest
HALB
Halberd
0.0$0.04flat$0.00N/A0.00Gap Down
HAVN Life Sciences logo
HAVLF
HAVN Life Sciences
0.0$0.57flat$0.00N/A0.00Decrease in Short Interest
Gap Down
Idorsia logo
IDRSF
Idorsia
0.5$27.74flat$0.00N/A0.00
IPATF
ImmunoPrecise Antibodies
0.5N/AN/A$0.00N/A0.00High Trading Volume
IMLFF
InMed Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Innovation Pharmaceuticals logo
IPIX
Innovation Pharmaceuticals
0.6$0.26flat$0.00N/A0.00Gap Down
Kalytera Therapeutics logo
KALTF
Kalytera Therapeutics
0.6$0.05flat$0.00N/A0.00Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00flat$0.00N/A0.00
Mesoblast logo
MEOBF
Mesoblast
0.5$1.73flat$0.00N/A0.00
MCURF
Mind Cure Health
0.0$0.32flat$0.00N/A0.00Increase in Short Interest
Gap Down
Mind Medicine (MindMed) logo
MMEDF
Mind Medicine (MindMed)
1.1$2.43flat$0.00N/A0.00
Molecular Partners logo
MLLCF
Molecular Partners
0.5$26.25flat$0.00N/A0.00News Coverage
MPSYF
MorphoSys
0.0$92.50flat$0.00N/A0.00
NRNVF
Nordic Nanovector ASA
0.0$1.64flat$0.00N/A0.00High Trading Volume
Novozymes A/S logo
NVZMF
Novozymes A/S
0.4$64.87flat$0.00N/A0.00
BPSR
Organicell Regenerative Medicine
0.5$0.05flat$0.00N/A0.00Increase in Short Interest
Gap Down
Oxurion logo
TBGNF
Oxurion
0.5$2.94flat$0.00N/A0.00News Coverage
Pharnext logo
PNEXF
Pharnext
0.0$4.11flat$0.00N/A0.00
PTEO
Proteo
0.5$0.09flat$0.00N/A0.00
PROT
Proteonomix
0.5$0.01flat$0.00N/A0.00Increase in Short Interest
ProtoKinetix logo
PKTX
ProtoKinetix
0.5$0.18flat$0.00N/A0.00High Trading Volume
Decrease in Short Interest
Gap Down
PureTech Health logo
PTCHF
PureTech Health
0.0$5.73flat$0.00N/A0.00Decrease in Short Interest
News Coverage
RCPHF
Recipharm AB (publ)
1.0$16.05flat$0.00N/A0.00High Trading Volume
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.